Patients with frequently recurring genital herpes were enrolled in a double-blind placebo-controlled trial comparing 200-mg acyclovir capsules, given five or two times daily, with placebo. Of 47 placebo recipients, 44 (94 per cent) had recurrences during the 120-day treatment period, compared with 13 (29 per cent) of 45 patients treated with acyclovir five times daily and 18 of 51 (35 per cent) treated with acyclovir twice daily (P less than 0.001 for each regimen compared with placebo). The median time to the first clinical recurrence was 18 days in placebo recipients, compared with over 120 days in both acyclovir-treated groups (P less than 0.001 for both groups compared with placebo). The mean monthly recurrence rate during the medication period was 0.86 in placebo recipients, compared with 0.13 in patients treated with acyclovir five times daily and 0.14 in patients treated with acyclovir twice daily (P less than 0.001 for both groups compared with placebo). While receiving therapy, 86 of 96 acyclovir-treated patients had over a 50 per cent reduction in their pretreatment recurrence rate. Breakthrough recurrences in acyclovir recipients were of shorter duration and associated with a lower frequency of viral shedding than recurrences in placebo recipients. After medication was discontinued, the subsequent recurrence rate returned to pretreatment frequencies. Daily oral acyclovir was well tolerated. We conclude that oral acyclovir given for four months markedly reduces but does not completely prevent recurrences of genital herpes and does not influence the long-term natural history of the disease.
This article has been cited by other articles:
Cernik, C., Gallina, K., Brodell, R. T.
(2008). The Treatment of Herpes Simplex Infections: An Evidence-Based Review. Arch Intern Med
168: 1137-1144
[Abstract][Full Text]
Fife, K. H., Meng, T.-C., Ferris, D. G., Liu, P.
(2008). Effect of Resiquimod 0.01% Gel on Lesion Healing and Viral Shedding When Applied to Genital Herpes Lesions. Antimicrob. Agents Chemother.
52: 477-482
[Abstract][Full Text]
Kimberlin, D. W., Rouse, D. J.
(2004). Genital Herpes. NEJM
350: 1970-1977
[Full Text]
Corey, L., Wald, A., Patel, R., Sacks, S. L., Tyring, S. K., Warren, T., Douglas, J. M. Jr., Paavonen, J., Morrow, R. A., Beutner, K. R., Stratchounsky, L. S., Mertz, G., Keene, O. N., Watson, H. A., Tait, D., Vargas-Cortes, M., the Valacyclovir HSV Transmission Study Group,
(2004). Once-Daily Valacyclovir to Reduce the Risk of Transmission of Genital Herpes. NEJM
350: 11-20
[Abstract][Full Text]
Schacker, T. W., Conant, M., Thoming, C., Stanczak, T., Wang, Z., Smith, M.
(2002). Imiquimod 5-Percent Cream Does Not Alter the Natural History of Recurrent Herpes Genitalis: a Phase II, Randomized, Double-Blind, Placebo-Controlled Study. Antimicrob. Agents Chemother.
46: 3243-3248
[Abstract][Full Text]
Mindel, A, Taylor, J, Tideman, R L, Seifert, C, Berry, G, Wagner, K, Page, J, Marks, C, Trudinger, B, Cunningham, A
(2000). Neonatal herpes prevention: a minor public health problem in some communities. Sex. Transm. Infect.
76: 287-291
[Abstract][Full Text]
Ashley, R. L., Wald, A.
(1999). Genital Herpes: Review of the Epidemic and Potential Use of Type-Specific Serology. Clin. Microbiol. Rev.
12: 1-8
[Abstract][Full Text]
Diaz-Mitoma, F., Sibbald, R. G., Shafran, S. D., Boon, R., Saltzman, R. L., for the Collaborative Famciclovir Genital Herpes R,
(1998). Oral Famciclovir for the Suppression of Recurrent Genital Herpes: A Randomized Controlled Trial. JAMA
280: 887-892
[Abstract][Full Text]
Bachman, D. M., Barron, B. A.
(1998). Prevention of Herpes Simplex Keratitis and Iritis. Arch Ophthalmol
116: 259-259
[Full Text]
Mertz, G. J., Loveless, M. O., Levin, M. J., Kraus, S. J., Fowler, S. L., Goade, D., Tyring, S. K.
(1997). Oral Famciclovir for Suppression of Recurrent Genital Herpes Simplex Virus Infection in Women: A Multicenter, Double-Blind, Placebo-Controlled Trial. Arch Intern Med
157: 343-349
[Abstract]
Spruance, S. L., Tyring, S. K., DeGregorio, B., Miller, C., Beutner, K.
(1996). A Large-Scale, Placebo-Controlled, Dose-Ranging Trial of Peroral Valaciclovir for Episodic Treatment of Recurrent Herpes Genitalis. Arch Intern Med
156: 1729-1735
[Abstract]
Sacks, S. L., Aoki, F. Y., Diaz-Mitoma, F., Sellors, J., Shafran, S. D.
(1996). Patient-Initiated, Twice-Daily Oral Famciclovir for Early Recurrent Genital Herpes: A Randomized, Double-blind Multicenter Trial. JAMA
276: 44-49
[Abstract]
Kost, R. G., Hill, E. L., Tigges, M., Straus, S. E.
(1993). Recurrent Acyclovir-Resistant Genital Herpes in an Immunocompetent Patient. NEJM
329: 1777-1782
[Full Text]
Mertz, G. J., Benedetti, J., Ashley, R., Selke, S. A., Corey, L.
(1992). Risk Factors for the Sexual Transmission of Genital Herpes. ANN INTERN MED
116: 197-202
[Abstract]
Kaplowitz, L. G., Baker, D., Gelb, L., Blythe, J., Hale, R., Frost, P., Crumpacker, C., Rabinovich, S., Peacock, J. E. Jr, Herndon, J., Davis, L. G., the Acyclovir Study Group,
(1991). Prolonged Continuous Acyclovir Treatment of Normal Adults With Frequently Recurring Genital Herpes Simplex Virus Infection. JAMA
265: 747-751
[Abstract]
Rand, K. H., Hoon, E. F., Massey, J. K., Johnson, J. H.
(1990). Daily Stress and Recurrence of Genital Herpes Simplex. Arch Intern Med
150: 1889-1893
[Abstract]
Brock, B. V., Selke, S., Benedetti, J., Douglas, J. M. Jr, Corey, L.
(1990). Frequency of Asymptomatic Shedding of Herpes Simplex Virus in Women With Genital Herpes. JAMA
263: 418-420
[Abstract]
Sacks, S. L., Wanklin, R. J., Reece, D. E., Hicks, K. A., Tyler, K. L., Coen, D. M.
(1989). Progressive Esophagitis from Acyclovir-Resistant Herpes Simplex: Clinical Roles for DNA Polymerase Mutants and Viral Heterogeneity?. ANN INTERN MED
111: 893-899
[Abstract]
Beyer, C. F., Arens, M. Q., Hill, G. A., Rose, B. T., Beyer, L. R., Schanzlin, D. J.
(1989). Oral Acyclovir Reduces the Incidence of Recurrent Herpes Simplex Keratitis in Rabbits After Penetrating Keratoplasty. Arch Ophthalmol
107: 1200-1205
[Abstract]
Straus, S. E., Croen, K. D., Sawyer, M. H., Freifeld, A. G., Felser, J. M., Dale, J. K., Smith, H. A., Hallahan, C., Lehrman, S. N.
(1988). Acyclovir Suppression of Frequently Recurring Genital Herpes: Efficacy and Diminishing Need During Successive Years of Treatment. JAMA
260: 2227-2230
[Abstract]
Spruance, S. L., Hamill, M. L., Hoge, W. S., Davis, L. G., Mills, J.
(1988). Acyclovir Prevents Reactivation of Herpes Simplex Labialis in Skiers. JAMA
260: 1597-1599
[Abstract]
Mertz, G. J., Jones, C. C., Mills, J., Fife, K. H., Lemon, S. M., Stapleton, J. T., Hill, E. L., Davis, L. G., the Acyclovir Study Group,
(1988). Long-term Acyclovir Suppression of Frequently Recurring Genital Herpes Simplex Virus Infection: A Multicenter Double-blind Trial. JAMA
260: 201-206
[Abstract]
Rompalo, A. M., Mertz, G. J., Davis, L. G., Benedetti, J., Critchlow, C., Stamm, W. E., Corey, L.
(1988). Oral Acyclovir for Treatment of First-Episode Herpes Simplex Virus Proctitis. JAMA
259: 2879-2881
[Abstract]
WHITLEY, R. J.
(1988). Ganciclovir--Have We Established Clinical Value in the Treatment of Cytomegalovirus Infections?. ANN INTERN MED
108: 452-454
[Abstract]
DORSKY, D. I., CRUMPACKER, C. S.
(1987). Drugs Five Years Later: Acyclovir. ANN INTERN MED
107: 859-874
[Abstract]
PETERSON, P., STAHL-BAYLISS, C. M.
(1987). Cytomegalovirus Thrombophlebitis After Successful DHPG Therapy. ANN INTERN MED
106: 632-633
[Abstract]
Kaplan, L. D., Wofsy, C. B., Volberding, P. A.
(1987). Treatment of Patients With Acquired Immunodeficiency Syndrome and Associated Manifestations. JAMA
257: 1367-1374
[Abstract]
Dan, M., Siegman-Igra, Y., Weinberg, M., Michaeli, D.
(1986). Long-term Suppression of Recurrent Herpes Labialis by Low-Dose Oral Acyclovir in an Immunocompromised Patient. Arch Intern Med
146: 1438-1440
[Abstract]
LEHRMAN, S. N., DOUGLAS, J. M., COREY, L., BARRY, D. W.
(1986). Recurrent Genital Herpes and Suppressive Oral Acyclovir Therapy: Relation Between Clinical Outcome and In-Vitro Drug Sensitivity. ANN INTERN MED
104: 786-790
[Abstract]
Guinan, M. E.
(1986). Oral Acyclovir for Treatment and Suppression of Genital Herpes Simplex Virus Infection: A Review. JAMA
255: 1747-1749
[Abstract]
Seale, L., Jones, C. J., Kathpalia, S., Jackson, G. G., Mozes, M., Maddux, M. S., Packham, D.
(1985). Prevention of Herpesvirus Infections in Renal Allograft Recipients by Low-Dose Oral Acyclovir. JAMA
254: 3435-3438
[Abstract]
STRAUS, S. E., ROONEY, J. F., SEVER, J. L., SEIDLIN, M., NUSINOFF-LEHRMAN, S., CREMER, K.
(1985). Herpes Simplex Virus Infection: Biology, Treatment, and Prevention. ANN INTERN MED
103: 404-419
[Abstract]
SHEPP, D. H., NEWTON, B. A., DANDLIKER, P. S., FLOURNOY, N., MEYERS, J. D.
(1985). Oral Acyclovir Therapy for Mucocutaneous Herpes Simplex Virus Infections in Immunocompromised Marrow Transplant Recipients. ANN INTERN MED
102: 783-785
[Abstract]
GREEN, J. A., SPRUANCE, S. L., WENERSTROM, G., PIEPKORN, M. W.
(1985). Post-Herpetic Erythema Multiforme Prevented with Prophylactic Oral Acyclovir. ANN INTERN MED
102: 632-633
[Abstract]
Marlowe, S. I.
(1985). Medical Management of Genital Herpes: Advances in Antiviral Treatment. Arch Dermatol
121: 467-470
[Abstract]
LASKIN, O. L.
(1985). Acyclovir and Suppression of Frequently Recurring Herpetic Whitlow. ANN INTERN MED
102: 494-495
[Abstract]
Dolin, R
(1985). Antiviral chemotherapy and chemoprophylaxis. Science
227: 1296-1303
[Abstract]
Previous
